Abstract | CONTEXT: OBJECTIVE: To investigate the mechanism of Sch A in AD. MATERIALS AND METHODS: AD group: APP/PS1 transgenic mice served as AD models; AD + SCH group: APP/PS1 received 2 mg/kg Sch A by intragastric administration; WT: C57BL/6 mice were used as control. For in vitro assay, mouse microglial BV2 cells were treated with 0.5 µg/mL lipopolysaccharide or combined with 10 μmol/L Sch A for 24 h. The cognitive function and apoptosis in the mice was estimated. Microglial polarisation in the mice and cells was analysed. RESULTS: Sch A treatment effectively improved spatial learning and memory ability and suppressed apoptosis in the brain tissues of APP/PS1 mice. APP/PS1 mice exhibited an increase in the levels of Aβ1-42 (2367.9 ± 431.1 pg/mg) and Aβ1-40 (1753.3 ± 253.4 pg/mg), which was abolished by Sch A treatment. Moreover, Sch A treatment repressed the proportions of iNOS+/Iba-1+ cells and IL-6 expression, while enhanced the proportions of Arg-1+/Iba-1+ cells and IL-10 expression in APP/PS1 mice. In vitro, Sch A treatment reduced the proportions of CD16/32+ cells, iNOS expression and IL-6 levels (25.7 ± 5.3 pg/mL) repressed M1 polarisation, and enhanced the proportions of CD206 cells, Arg-1 expression and IL-10 levels (75.9 ± 12.8 pg/mL) in BV2 cells. CONCLUSIONS: This research confirms the neuroprotective effect of Sch A in AD, suggesting that Sch A may become a potential anti-AD agent.
|
Authors | Qi Wang, Li Liu, Huibo Guan, Yanyan Zhou, Quan Li |
Journal | Pharmaceutical biology
(Pharm Biol)
Vol. 59
Issue 1
Pg. 860-867
(Dec 2021)
ISSN: 1744-5116 [Electronic] England |
PMID | 34214019
(Publication Type: Journal Article)
|
Chemical References |
- Cyclooctanes
- Lignans
- Neuroprotective Agents
- Polycyclic Compounds
- schizandrin A
|
Topics |
- Alzheimer Disease
(drug therapy, physiopathology)
- Animals
- Apoptosis
(drug effects)
- Brain
(drug effects, physiopathology)
- Cell Line
- Cognition
(drug effects)
- Cyclooctanes
(isolation & purification, pharmacology)
- Disease Models, Animal
- Lignans
(isolation & purification, pharmacology)
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Microglia
(drug effects, metabolism)
- Neuroprotective Agents
(isolation & purification, pharmacology)
- Polycyclic Compounds
(isolation & purification, pharmacology)
- Schisandra
(chemistry)
|